Sangamo Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in research and development of some of their therapeutic treatments.
“Novel ZFP Therapeutic Approach Selectively Represses Expression of Huntington’s Disease-Causing Gene Variant in Patient-Derived Cells and Animal Models”
Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is a clinical-stage biotechnology company. The Company is focused on translating science into genomic therapies that transform patients’ lives using the Company’s platform technologies in genome editing, gene therapy, gene regulation and cell therapy. [Source: Reuters]
Company Website: http://www.sangamo.com/